Related Experiment Video
Updated: Sep 5, 2025

Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Aseptic osteonecrosis of the maxilla after severe COVID-19 infection and its treatment
1Department of diagnostic imaging, University Hospital "St. Ekaterina", Medical University, Pencho Slaveikov 52A, 143, Sofia, Bulgaria.
Abstract:
The course of the new SARS-CoV-2 (COVID-19) is unpredictable and is still being investigated. Although the majority of complications are expected to affect the respiratory system, there have been reports in literature concerning the adverse effects of the infection on bone and joint tissue. Several complications have been observed in the maxillofacial area in people who suffered from the infection, including osteonecrosis and osteomyelitis of the jaw. These complications have been subject to various hypotheses. They may result either from the disease pathogenetic mechanism or from a response to the therapeutic modalities used to treat the underlying disease, and overuse of particular medications - glucocorticoids, antirheumatics, interleukin-6 inhibitors, and antibiotics. This article presents a case of osteonecrosis of the maxilla after severe COVID-19 infection.
Related Concept Videos
Tonsillitis II: Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis III: Medical Management
Acute Pancreatitis II: Clinical Manifestations and Management

